Changes in Healthcare Utilization During the COVID-19 Pandemic and Potential Causes-A Cohort Study From Switzerland

Int J Public Health. 2023 Jul 26:68:1606010. doi: 10.3389/ijph.2023.1606010. eCollection 2023.

Abstract

Objectives: To describe the frequency of and reasons for changes in healthcare utilization in those requiring ongoing treatment, and to assess characteristics associated with change, during the second wave of the pandemic. Methods: Corona Immunitas e-cohort study (age ≥20 years) participants completed monthly questionnaires. We compared participants reporting a change in healthcare utilization with those who did not using descriptive and bivariate statistics. We explored characteristics associated with the number of changes using negative binomial regression. Results: The study included 3,190 participants from nine research sites. One-fifth reported requiring regular treatment. Among these, 14% reported a change in healthcare utilization, defined as events in which participants reported that they changed their ongoing treatment, irrespective of the reason. Reasons for change were medication changes and side-effects, specifically for hypertension, or pulmonary embolism treatment. Females were more likely to report changes [Incidence Rate Ratio (IRR) = 2.15, p = 0.002]. Those with hypertension were least likely to report changes [IRR = 0.35, p = 0.019]. Conclusion: Few of those requiring regular treatment reported changes in healthcare utilization. Continuity of care for females and chronic diseases besides hypertension must be emphasized.

Keywords: COVID-19; digital follow-up; healthcare delivery; healthcare utilization; population-based study.

MeSH terms

  • Adult
  • COVID-19* / epidemiology
  • Cohort Studies
  • Female
  • Humans
  • Hypertension*
  • Pandemics
  • Patient Acceptance of Health Care
  • Switzerland / epidemiology
  • Young Adult

Grants and funding

This study is part of Corona Immunitas research network, coordinated by the Swiss School of Public Health (SSPH+), and funded by fundraising of SSPH+ including funds of the Swiss Federal Office of Public Health and private funders (ethical guidelines for funding stated by SSPH+ were respected), by funds of the Canton of Zurich and by institutional funds of the Universities. The center Basel was additionally funded as part of COVCO Basel by the cantons Basel-Stadt and Basel-Landschaft. The funding bodies had no influence on the design, conduct, analysis, or interpretation of the study, as well as on the decision to publish, preparation or revisions of the manuscript.